避孕藥市場規模、佔有率、成長分析、按產品、分銷管道、按地區 - 行業預測，2024-2031

2022年避孕藥具市場規模為282.2億美元，從2023年的303.1億美元成長到2031年的536.5億美元，複合年成長率預計為7.40%。

由於計劃生育意識不斷提高、性行為感染感染 (STI) 發病率上升以及對有效避孕解決方案的需求不斷成長，全球避孕藥市場正在強勁成長。包括長效可逆避孕藥（LARC）和多樣化可用選擇在內的關鍵進步正在進一步刺激市場擴張。政府促進生殖健康的措施正在改善市場條件。然而，社會恥辱、文化障礙和某些領域的准入有限等挑戰可能會阻礙成長。儘管存在這些障礙，但由於人們對婦女健康的認知不斷提高以及人們普遍接受避孕作為賦權工具，全球避孕市場預計將繼續成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析
• 貿易分析
• 原料分析

避孕藥具市場規模：依產品分類

• 市場概況
• 避孕藥
  • 避孕藥
  • 修補
  • 注射
• 避孕器
  • 保險套
  • 男用保險套
  • 女性用保險套
  • 皮下植入
  • 子宮內避孕器 (IUDS)
  • 銅子宮內避孕器
  • 荷爾蒙子宮內避孕器
  • 避孕環
  • 隔膜

避孕藥具市場規模：依通路分類

• 市場概況
• 醫療機構
• 藥局
• 其他

避孕藥具市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Bayer AG
• Pfizer Inc.
• Merck & Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Organon & Co.
• Agile Therapeutics
• Mayer Laboratories, Inc.
• CooperSurgical, Inc.
• Afaxys, Inc.
• Mylan NV（Viatris）
• DKT International
• Medisafe Distribution Inc.
• Veru Inc.
• Cipla Ltd.
• Lupin Pharmaceuticals
• Mithra Pharmaceuticals
• Pregna International Limited
• Fuji Latex Co., Ltd.
• Karex Berhad
• Cupid Limited

結論和建議

Contraceptives Market size was valued at USD 28.22 billion in 2022 and is poised to grow from USD 30.31 billion in 2023 to USD 53.65 billion by 2031, growing at a CAGR of 7.40% in the forecast period (2024-2031).

The global contraceptives market is experiencing robust growth, propelled by heightened awareness of family planning, a rise in sexually transmitted infections (STIs), and an increased demand for effective contraceptive solutions. Key advancements, including long-acting reversible contraceptives (LARCs) and a diverse range of available options, are further stimulating market expansion. Government initiatives promoting reproductive health enhance market conditions. However, challenges such as social stigma, cultural barriers, and limited access in certain regions can hinder growth. Despite these obstacles, the growing focus on women's health and the broadening acceptance of contraception as a tool for empowerment are poised to foster continued growth in the global contraceptives market in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contraceptives market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contraceptives Market Segmental Analysis

Global Contraceptives Market is segmented by product, distribution channel and region. Based on product, the market is segmented into contraceptive drugs and contraceptive devices. Based on distribution channel, the market is segmented into healthcare facilities, pharmacies and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contraceptives Market

A major catalyst for the global contraceptives market is the rising awareness and acceptance surrounding family planning and reproductive health. As communities become more informed about the critical role of contraception in managing population growth and improving women's health, the demand for contraceptive options has surged considerably. This uptick is further bolstered by government initiatives and programs that advocate for family planning, as well as the dedicated efforts of various organizations working to enhance public understanding of contraceptive methods. Consequently, the convergence of education, policy support, and advocacy has fueled substantial growth within the contraceptives market.

Restraints in the Contraceptives Market

The global contraceptives market faces significant constraints primarily due to cultural and religious barriers that impede the acceptance and utilization of contraceptives in various regions. In many communities, prevailing cultural and religious norms discourage or outright prohibit contraceptive use, resulting in diminished adoption rates. Additionally, insufficient accessibility, particularly in rural and remote areas, compounds these challenges. Factors such as limited availability, high costs, and inadequate distribution networks further restrict access to contraceptives, especially in developing nations. Addressing these cultural and logistical obstacles is essential for fostering market expansion and achieving universal access to effective contraception methods.

Market Trends of the Contraceptives Market

The global contraceptives market is witnessing a significant trend towards the increasing adoption of long-acting reversible contraceptives (LARCs), such as intrauterine devices (IUDs) and contraceptive implants. These options are favored for their high efficacy and convenience, as they require minimal maintenance compared to traditional methods. As women seek reliable, hassle-free solutions, LARCs are becoming increasingly popular, reflecting a broader shift towards effective and sustainable contraceptive solutions. Technological advancements have further enhanced the appeal of LARCs, leading to the development of innovative, user-friendly products that cater to evolving consumer needs. This shift underscores a growing preference for modern contraceptive methods in the global market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Contraceptives Market Size by Product & CAGR (2024-2031)

• Market Overview
• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectables
• Contraceptive Devices
  • Condom
  • Male Condom
  • Female Condom
  • Subdermal Implants
  • Intrauterine Devices (IUDS)
  • Copper IUDS
  • Hormonal IUDS
  • Vaginal Ring
  • Diaphragm

Global Contraceptives Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Healthcare Facilities
• Pharmacies
• Others

Global Contraceptives Market Size & CAGR (2024-2031)

• North America (Product, Distribution Channel)
  • USA
  • Canada
• Europe (Product, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Karex Berhad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cupid Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations